88
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis

, , , , , , , , , , , & show all
Pages 519-524 | Published online: 17 May 2010

References

  • FintakDRGauravKSBlinderKJIncidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumabRetina2008281395139918827737
  • StepienKEEatonAMJaffeGJIncreased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006Retina20092920721319050670
  • RosenfeldPJMoshfeghiAAPuliafitoCAOptical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degenerationOphthalmic Surg Lasers Imaging20053633133516156152
  • GreenbergPBMartidisARogersAHDukerJSReichelEIntravitreal triamcinolone for the treatment of macular oedema due to central retinal vein occlusionBr J Ophthalmol20028624724811815359
  • HeierJSAntoszykANPavanPRRanibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose studyOphthalmology200611363364216483659
  • SchwartzSGFlynnHWScottIUEndophthalmitis after intravitreal injectionsExpert Opin Pharmacother2009132119212619586422
  • MasonJOMiltonFWFeistRMIncidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injectionRetina20082856456718398358
  • KleinKSWalshMKHassanTSEndophthalmitis after anti-VEGF injectionsOphthalmology2009116122519486799
  • BhavsarARGoogeJMStockdaleCRRisk of endophthalmitis after intravitreal drug injection when topical antibiotics are not requiredArch Ophthalmology200912715811583
  • DiagoTMcCannelCABakriSJPulidoJSEdwardsAOPachJMInfectious endophthalmitis after intravitral injection of antiangiogenic agentsRetina20092960160519357558
  • GragoudasESAdamisAPCunninghamETPegaptanib for neovascular age-related macular degenerationN Engl J Med20043512805281615625332
  • JonasJBSpandauUHRenschFVon BaltzSSchlichtenbredeFInfectious and noninfectious endophthalmitis after intravitreal bevacizumabJ Ocul Pharmacol Ther20072324024217593007
  • ArtunayOYuzbasiogluERasierRSengülABahceciogluHIncidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injectionEye2009232187219319218994
  • RosenfeldPJBrownMDHeierJSRanibizumab for neovascular age-related macular degenerationN Engl J Med20063551419143117021318
  • JonasJBKreissingISpandauUHHarderBInfectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonideAm J Ophthalmol200614157958016490517
  • RothDBFlynnHWDistinguishing between infectious and noninfectious endophthalmitis after intravitreal triamcinolone injectionAm J Ophthalmol200814634634718724979
  • DoftBHThe Endophthalmitis Vitrectomy StudyArch Ophthalmol19911094874892012545
  • FlynnHWScottIULegacy of the Vitrectomy StudyArch Ophthalmol200812655956118413530
  • ScottIUFlynnHWSundeepDEndophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomesRetina20082813814218185150
  • AielloLPBruckerAJChangSCunninghamETEvolving guidelines for intravitreal injectionsRetina2004S31915483476
  • SpeakerMGMenikoffJAProphylaxis of endophthalmitis with povidone-iodineOphthalmology199198176917751775308
  • ScottIUFlynnHWThe role of topical antibiotic prophylaxis for intravitreal injectionsArch Ophthalmol200712597497617620584